- Home
- / Central Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Central Pharma financials data including stock price, CreditSafe score, income statement, and balance sheet.
Revenue
£18.6 M
FY, 2022
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|
| Revenue | 11.9M | 16.5M | 18.6M |
| Cost of goods sold | 7.0M | 10.1M | 12.2M |
| Gross profit | 4.9M | 6.3M | 6.5M |
| Gross profit margin, % | 41.1% | 38.5% | 34.8% |
| General and administrative expense | 4.5M | 5.8M | 7.0M |
| Operating expense total | 4.5M | 5.8M | 7.0M |
| EBIT | 357.5K | 605.3K | (509.7K) |
| EBIT margin, % | 3.0% | 3.7% | -2.7% |
| Interest expense | 51.0K | 80.3K | 188.1K |
| Pre tax profit | 306.4K | 524.9K | (697.8K) |
| Income tax expense | 70.2K | 96.1K | (113.9K) |
| Net Income | 236.2K | 428.9K | (583.9K) |